BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26018682)

  • 1. Somatostatin Receptors in an Anaplastic Oligodendroglioma Relapse Evidenced By 68Ga DOTANOC PET/CT.
    Savelli G; Muni A
    Clin Nucl Med; 2015 Jul; 40(7):e363-5. PubMed ID: 26018682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relatively decreased 11C-methionine uptake within the anaplastic component of a mixed-grade oligodendroglioma.
    Miwa K; Shinoda J; Yano H; Iwama T
    AJNR Am J Neuroradiol; 2007; 28(10):2005-7. PubMed ID: 17905896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic melanoma to the thyroid gland expressing somatostatin receptors-imaging with 68Ga-DOTANOC PET/CT.
    Jung RS; Mittal BR; Bal A; Dey P; Shukla J; Kapoor R
    Clin Nucl Med; 2015 Feb; 40(2):175-6. PubMed ID: 25546189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET/CT.
    Xiao J; Zhu Z; Zhong D; Ma W; Wang R
    Clin Nucl Med; 2015 Feb; 40(2):e129-31. PubMed ID: 24873798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-DOTANOC somatostatin receptor PET-CT imaging in multiple myeloma.
    Sharma P; Dhull VS; Suman S; Bal C; Malhotra A; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):374-5. PubMed ID: 23640227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant Jugular Paraganglioma: Unusual Presentation on 68Ga DOTANOC PET/CT.
    Jain TK; Basher RK; Shukla J; Mittal BR; Panda NK
    Clin Nucl Med; 2016 Feb; 41(2):150-2. PubMed ID: 26646996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
    Ambrosini V; Campana D; Bodei L; Nanni C; Castellucci P; Allegri V; Montini GC; Tomassetti P; Paganelli G; Fanti S
    J Nucl Med; 2010 May; 51(5):669-73. PubMed ID: 20395323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal
    Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic 68Ga DOTANOC PET/CT in imaging of bladder paraganglioma.
    Dhull VS; Karunanithi S; Arora S; Jain TK; Kumar R
    Clin Nucl Med; 2014 Oct; 39(10):915-6. PubMed ID: 24566403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.
    Naswa N; Sharma P; Kumar A; Soundararajan R; Kumar R; Malhotra A; Ammini AC; Bal C
    Clin Nucl Med; 2012 Mar; 37(3):245-51. PubMed ID: 22310250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
    Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
    Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-DOTANOC PET-CT demonstrating in vivo somatostatin receptor expression in idiopathic gynecomastia.
    Dhull VS; Sharma P; Singla S; Singhal A; Bal C; Kumar R
    Clin Nucl Med; 2013 Aug; 38(8):e324-5. PubMed ID: 23531768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT.
    Arora S; Soundararajan R; Joshi P; Kumar R; Bal C
    Clin Nucl Med; 2015 Jun; 40(6):496-8. PubMed ID: 25546200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic neuroendocrine carcinoma presenting as a "Superscan" on 68Ga-DOTANOC somatostatin receptor PET/CT.
    Naswa N; Karunanithi S; Soundararajan R; Das KJ; Agarwal KK; Malhotra A; Bal C; Kumar R
    Clin Nucl Med; 2012 Sep; 37(9):892-4. PubMed ID: 22889781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of 68Ga DOTANOC PET/CT Imaging in Patients With Multiple Endocrine Neoplasia Syndromes.
    Sharma P; Mukherjee A; Karunanithi S; Naswa N; Kumar R; Ammini AC; Bal C
    Clin Nucl Med; 2015 Jul; 40(7):e351-6. PubMed ID: 25783509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga DOTANOC PET/CT detects primary malignant insulinoma.
    Ambrosini V; Campana D; Nanni C; Marzola MC; Rubello D; Fanti S
    Clin Nucl Med; 2015 Feb; 40(2):e132-3. PubMed ID: 24830876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified?
    Sharma P; Arora S; Mukherjee A; Pal S; Sahni P; Garg P; Khadgawat R; Thulkar S; Bal C; Kumar R
    Clin Nucl Med; 2014 Jan; 39(1):37-43. PubMed ID: 24152621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.